Page last updated: 2024-11-13

aspirin, butalbital and caffeine drug combination

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aspirin, butalbital and caffeine drug combination: combination drug of butalbital, caffeine and aspirin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID24847961
MeSH IDM0041327

Synonyms (19)

Synonym
51005-25-5
aspirin and caffeine w/ butalbital
butal compound
butalbital, aspirin and caffeine
butalbital w/ aspirin & caffeine
butalbital compound
butalbital aspirin and caffeine
aspirin, butalbital, caffeine drug combination
dolomo
aspirin - butalbital - caffeine
aspirin, butalbital and caffeine drug combination
butalbital, aspirin, and caffeine
benzoic acid, 2-(acetyloxy)-, mixt. with 3,7-dihydro-1,3,7-trimethyl-1h-purine-2,6-dione, and 5-(2-methylpropyl)-5-(2-propenyl)-2,4,6(1h,3h,5h)-pyrimidinetrione
b-a-c
marnal
fiorgen pf
isollyl improved
2-acetyloxybenzoic acid;5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione;1,3,7-trimethylpurine-2,6-dione
2-acetoxybenzoic acid compound with 1,3,7-trimethyl-3,7-dihydro-1h-purine-2,6-dione and 5-allyl-5-isobutylpyrimidine-2,4,6(1h,3h,5h)-trione (1:1:1)

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Its transnasal dosage form, which may be self-administered when the use of an opioid analgesic is appropriate, was previously shown to provide rapid relief of migraine pain."( Comparison of butorphanol nasal spray and fiorinal with codeine in the treatment of migraine.
Davidson, WJ; Diamond, S; Gawel, MJ; Goldstein, J; Reich, L; Sussman, NM; Winner, P,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (57.89)18.7374
1990's6 (31.58)18.2507
2000's2 (10.53)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.85 (24.57)
Research Supply Index3.26 (2.92)
Research Growth Index4.11 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials5 (25.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies5 (25.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (50.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]